Related Experiment Video
Updated: May 24, 2025
Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
Published on: October 26, 2017
Enhanced methodology for analysis cytotoxicity of ruthenium dendrimers
Aneta Węgierek-Ciuk1, Maria Baczewska2, Katarzyna Gałczyńska3
1Jan Kochanowski University, Institute of Biology, Uniwersytecka 7, 25-406 Kielce, Poland.
Abstract:
Resistance of cancer cells to chemotherapy is one of the major causes of treatment failure and poor patient survival. Reduced cellular response to drugs can result from their genetic diversity, acquired mutations of drug targets, epigenetic modifications and many others. Metallodendrimers, in particular, ruthenium dendrimers of the first and second generation are promising novel anticancer drug carriers, as their usage can result in increased drug concentration in tumour tissue and reduced toxicity in healthy tissues. However the conventional, biological methods do not provide sufficient knowledge about cytotoxicity of these compounds. Therefore in the paper we propose an efficient, multimodal methodology for cytotoxicity studies at cellular level. It combines the conventional flow cytometry method (Annexin V-FITC assay), which provides global/statistical information about a cell culture, and digital holographic microscopy (DHM) allowing for continuous quantitative monitoring of cells behaviour and identifying cells with non-standard behaviour. The results reveal that tested ruthenium metallodendrimers have a strong impact on apoptotic and necrotic death of both human alveolar epithelial cell line A549 and Chinese hamster ovary cell line CHO-K1. We also have shown that DHM enables detection of the individual, drug resistance cells, through real-time monitoring of a single cell. We believe that the methodology proposed is a necessary supplement to conventional approach for studying drug cytotoxicity, which will help, in the near future, to overcome the problem of cellular resistance to anticancer therapies.
Insights
This study introduces a new method combining flow cytometry and digital holographic microscopy (DHM) to study anticancer drug effectiveness. The multimodal approach enhances the understanding of ruthenium metallodendrimers
Area of Science:
- Nanotechnology and Materials Science
- Cell Biology and Toxicology
- Cancer Research
Background:
- Cancer cell resistance to chemotherapy is a primary reason for treatment failure and reduced patient survival.
- Conventional methods for assessing drug cytotoxicity offer limited insight into cellular resistance mechanisms.
- Ruthenium metallodendrimers show potential as anticancer drug carriers, improving tumor drug concentration and reducing systemic toxicity.
Purpose of the Study:
- To develop and validate an efficient, multimodal methodology for studying drug cytotoxicity at the cellular level.
- To combine flow cytometry with digital holographic microscopy (DHM) for comprehensive cytotoxicity assessment.
- To investigate the impact of ruthenium metallodendrimers on cancer cell death and identify drug-resistant cells.
Main Methods:
- Utilized a multimodal approach integrating Annexin V-FITC assay via flow cytometry for global cell culture analysis.
- Employed digital holographic microscopy (DHM) for continuous, quantitative monitoring of individual cell behavior.
- Applied the combined methodology to assess the cytotoxicity of ruthenium metallodendrimers on A549 and CHO-K1 cell lines.
Main Results:
- Ruthenium metallodendrimers significantly induced apoptotic and necrotic cell death in both A549 and CHO-K1 cell lines.
- Digital holographic microscopy (DHM) successfully identified individual drug-resistant cells through real-time single-cell monitoring.
- The multimodal methodology provides a more detailed understanding of drug-induced cellular responses compared to conventional methods.
Conclusions:
- The proposed multimodal methodology is a valuable supplement to conventional approaches for drug cytotoxicity studies.
- This integrated method enhances the ability to study and potentially overcome cellular resistance to anticancer therapies.
- Ruthenium metallodendrimers demonstrate significant cytotoxic effects, and DHM offers a novel way to track resistance.
More Related Videos
08:46Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications
Published on: April 21, 2022
10:51The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
Published on: April 10, 2015